Neuronetics (STIM) Asset Writedowns and Impairment (2022 - 2026)

Neuronetics (STIM) has 5 years of Asset Writedowns and Impairment data on file, last reported at -$30000.0 in Q1 2026.

• On a quarterly basis, Asset Writedowns and Impairment fell 700.0% year-over-year to -$30000.0 in Q1 2026; TTM through Mar 2026 was $353000.0, a 36.96% decrease from a year earlier, with the FY2025 full-year figure at $388000.0, down 38.02% from the prior year.
• Asset Writedowns and Impairment for Q1 2026 stood at -$30000.0, down from $6000.0 in the prior quarter.
• Over the last five years, Asset Writedowns and Impairment for STIM reached as high as $1.9 million in Q3 2023 and fell as low as -$596000.0 in Q2 2023.
• Historically, Asset Writedowns and Impairment has averaged $297642.9 across 5 years, with a median of $74500.0 in 2024.
• Across the five-year window, Asset Writedowns and Impairment soared 11715.38% in 2023 and tumbled 700.0% in 2026, its largest moves.
• Year by year, Asset Writedowns and Impairment stood at $13000.0 in 2022, then surged by 11715.38% to $1.5 million in 2023, then tumbled by 81.77% to $280000.0 in 2024, then sank by 97.86% to $6000.0 in 2025, then plunged by 600.0% to -$30000.0 in 2026.
• Per Business Quant data, the three most recent Asset Writedowns and Impairment figures were -$30000.0 in Q1 2026, $6000.0 in Q4 2025, and $299000.0 in Q3 2025.